Flowvium
Back to Explorer

The Ensign Group

ENSGleader

Ensign Group is the largest US skilled-nursing and post-acute care operator (280+ SNFs), distinguished by a highly decentralized operating model that consistently outperforms industry occupancy and quality metrics.

Share:
Compare

Products & Revenue

Product Revenue Share

Revenue Breakdown ($4.70B)

Static data (loading live financials…)

Skilled Nursing / Post-Acute (80%)
Home Health & Hospice (15%)
Senior Living & Other (5%)

Segment Breakdown & Key Customers

Product Details

Skilled Nursing Facilities (SNF)80%

280+ skilled nursing facilities providing short-term rehab and long-term care — core business funded largely by Medicare/Medicaid.

Home Health & Hospice15%

In-home nursing care, physical therapy, and end-of-life hospice services in 100+ markets.

Senior Living5%

Assisted living and memory care communities adjacent to SNF campuses.

Macro & Market Context

헬스케어Sector News

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Upcoming Catalysts

CMS 메디케어 최종 수가 발표 (2026.Q2)UNH/HUM/CVS Q1 실적 (2026.04)IRA 약가 협상 2차 품목 공개

Latest News

Loading news...

AI Analysis

Click "Get AI Analysis" for an AI-powered supply chain analysis of The Ensign Group.

Company Info

Headquarters

San Juan Capistrano, California, USA

Founded

1999

Employees

70,000

Sector Overview헬스케어

Sector News

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Key Themes

  • CMS 메디케어 어드밴티지 수가 인하 → 보험사 마진 압박
  • AI 영상진단·병리학 도입 가속 — Tempus, Veracyte 수혜
  • GLP-1 보험 적용 확대 논의 → UNH·CVS 비용 증가 리스크

Upcoming Catalysts

  • CMS 메디케어 최종 수가 발표 (2026.Q2)
  • UNH/HUM/CVS Q1 실적 (2026.04)